NavaX will revolutionize end-to-end research and development processes with the latest cutting-edge technologies
BOSTON, December 15, 2023 /PRNewswire/ — ArisGlobal, a market leader in life sciences technology and creator of LifeSphere®, launched today LifeSphere NavaX, a cutting-edge cognitive computing engine to accelerate the digitalization of IT in R&D leveraging cutting-edge technologies including Large Language Models (LLM) and Generative AI (Gen AI).
LifeSphere is the industry’s leading R&D compliance platform. In 2018, the company launched LifeSphere MultiVigilance (LSMV), a platform for receiving Individual Safety Reports (ICSR). LSMV was powered by LifeSphere Nava (v1) – when introduced, LifeSphere Nava offered the latest robotic process automation and cognitive computing technologies, including natural language processing (NLP) and machine learning (ML), to transform pharmacovigilance (PV) activities.
Today, LifeSphere NavaX includes next-generation technologies that will deliver comprehensive efficiencies across end-to-end PV and regulatory processes. Organizations leveraging LifeSphere NavaX will benefit from the latest developments from ArisGlobal, including:
- Proactive signal detection (with the use of real data),
- Generative AI (Gen AI), and
- Characteristics and functionalities of large language models (LLM)
Half (49%) of all life sciences organizations mentioned their desire to deploy generative AI in the next 12 months in a survey conducted for the Gartner 2024 CIO Agenda. It appears that 15% of organizations are moving towards deployment within 12-24 months while only 8% have already deployed the technology. The growing appetite for intelligent process automation reflects increasing pressure on life sciences companies and their PV and regulatory operations. Companies are under pressure to be more agile and efficient, and to meet the highest standards of patient safety while improving quality and compliance.
Aman Wasan, CEO of ArisGlobal, said: “Our vision is to transform the R&D IT ecosystem with cutting-edge technology. NavaX will help global pharmaceutical, biotechnology and health authorities achieve greater value by leveraging cutting-edge technology. With over 30 years of experience in the life sciences industry, the ArisGlobal team will work closely with each customer to achieve exceptional benefits with NavaX. »
Ann-Marie Orange, Director of IT and Global Head of R&D at ArisGlobal said: “Businesses are facing colossal challenges, including increasing of case volume, the balance between the need to improve the safety and effectiveness of medicines while limiting increasing R&D costs, responding to regulatory complexity and the increasing pressure to exploit big data and analytics. In addition to these challenges, there remain inefficient existing IT systems, workflows and processes, as well as budget and resource constraints. » Ms. Orange adds: “Our LifeSphere platform codifies decades of R&D and compliance expertise, making it available to our clients. LifeSphere NavaX builds on our proven platform, enabling the life sciences industry to access the digital innovations that move the world forward. »
NavaX Technology Highlights
- NavaX is scalable and customizable; allows PV and regulatory teams to stay in control and set their own pace based on their objectives, goals, and timeline.
- NavaX supercharges LifeSphere solutions, which integrate seamlessly with third-party systems to ensure a smooth transition to a more intelligent and automated future.
- NavaX is built and improved with continuous input from pharmaceutical and regulatory partners, with the highest standards in establishing robust governance frameworks and compliance standards.
Today, more than 500 global pharmaceutical and biotechnology companies (90% of the top 10 pharmaceutical brands) leverage LifeSphere, ArisGlobal’s open R&D and compliance platform that is transforming the way pharmaceutical companies life sciences develop breakthroughs and bring new treatments to patients faster. Current customers of the LifeSphere platform have realized exceptional efficiencies and cost savings. By fueling next-generation digital process innovation, NavaX will boost operational efficiency, further accelerate information collection time and ensure greater compliance.
To learn more about LifeSphere NavaX, click here.
About ArisGlobal
ArisGlobal is the creator of LifeSphere, a market leader in technology solutions for patient care globally, transforming the way the most successful life sciences companies develop solutions innovative and bring new products to the market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. To learn more, follow ArisGlobal on LinkedIn and visit:www.arisglobal.com.